Risk factors for hepatocellular carcinoma development in patients with chronic HBV infection during nucleos(t)ide analogues therapy: a result of 10-year follow up
单位：[1]Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China临床科室国家中心肝病分中心首都医科大学附属北京友谊医院[2]National Clinical Research Center for Digestive Disease, Beijing, China
第一作者单位：[1]Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China[2]National Clinical Research Center for Digestive Disease, Beijing, China
推荐引用方式(GB/T 7714)：
Zhang Wei,Wang Xiaoming,Wang Yu,et al.Risk factors for hepatocellular carcinoma development in patients with chronic HBV infection during nucleos(t)ide analogues therapy: a result of 10-year follow up[J].HEPATOLOGY.2017,66:751A-752A.
APA：
Zhang, Wei,Wang, Xiaoming,Wang, Yu,Zhao, Xin-Yan,Duan, Weijia...&Jia, Jidong.(2017).Risk factors for hepatocellular carcinoma development in patients with chronic HBV infection during nucleos(t)ide analogues therapy: a result of 10-year follow up.HEPATOLOGY,66,
MLA：
Zhang, Wei,et al."Risk factors for hepatocellular carcinoma development in patients with chronic HBV infection during nucleos(t)ide analogues therapy: a result of 10-year follow up".HEPATOLOGY 66.(2017):751A-752A
医学